{
  "@context": {
    "bioagents": "https://bio.agents/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.agents/CGIdb",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalAgent/0.6-DRAFT",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_3360"
        },
        {
          "@id": "edam:topic_2640"
        },
        {
          "@id": "edam:topic_0208"
        }
      ],
      "sc:citation": [
        "pmcid:PMC6700431",
        "pubmed:31400611",
        {
          "@id": "https://doi.org/10.1016/J.OMTN.2019.07.003"
        }
      ],
      "sc:description": "Genetic Interaction-Based Biomarkers Identification for Drug Resistance and Sensitivity in Cancer Cells | Cancer cells generally harbor hundreds of alterations in the cancer genomes and act as crucial factors in the development and progression of cancer | However, detection of genetic interactions in the cancer genome is a major obstacle in the research of identifying biomarkers for cancer cell drug resistance and sensitivity",
      "sc:featureList": {
        "@id": "edam:operation_3501"
      },
      "sc:name": "CGIdb",
      "sc:url": "http://www.medsysbio.org/CGIdb"
    },
    {
      "@id": "https://doi.org/10.1016/J.OMTN.2019.07.003",
      "@type": "sc:CreativeWork"
    }
  ]
}